Opinion

NetFuel, Inc. v. Cisco Systems Inc.

Court
District Court, N.D. California
Filed
Mar 17, 2020
Cited by
0 cases
Authority
More cited than 18.6%

“Under Daubert, the district judge is ‘a 13 gatekeeper, not a fact finder.’”

How later courts described this case

  • “Under Daubert, the district judge is ‘a 13 gatekeeper, not a fact finder.’”
  • “[N]othing 3 precludes Zimmer from arguing for a narrower application of the limitation on the infringement 4 context, while also arguing, in the alternative, that . . . the patent claim would be so broad as to be 5 invalid.”
  • stating that the lack of quantitative support would “alone 25 justify” excluding the expert’s opinions at trial
  • “When reviewing damages in patent cases, we apply regional circuit law to procedural issues and Federal Circuit law to substantive and procedural issues ‘pertaining to patent 26 law.’” (citation omitted)

Written by the judges who cited it.

The opinion

1

2

3

4 UNITED STATES DISTRICT COURT

5 NORTHERN DISTRICT OF CALIFORNIA

6 SAN JOSE DIVISION

7

NETFUEL, INC.,

8 Case No. 5:18-cv-02352-EJD

Plaintiff,

9 ORDER DENYING PLAINTIFF’S

v. MOTION TO STRIKE; GRANTING

10 DEFENDANT’S MOTION TO STRIKE

CISCO SYSTEMS INC.,

11 Re: Dkt. Nos. 256, 258

Defendant.

12

13 The Parties have filed motions to exclude portions of the opposing sides’ expert testimony.

14 The Court finds these motions suitable for consideration without oral argument. See N.D. Cal.

15 Civ. L.R. 7-1(b). Having considered the Parties’ papers, the Court DENIES Plaintiff’s motion to

16 strike portions of Dr. Almeroth’s expert reports and GRANTS Defendant’s motion to strike

17 portions of Dr. Rubin and Mr. Bratic’s expert reports.1

18 I. BACKGROUND

19 A. Factual Background

20 Plaintiff alleges that Defendant infringed two of its patents. The Patents-in-Suit—U.S.

21 Patent Nos. 7,747,730 (the “’730 Patent”) and 9,663,659 (the “’659 Patent”)—disclose the use of

22 software programs called “agents” to monitor and manage computer networks and the devices

23 (such as routers and switches) that run those networks. Plaintiff accuses four features of

24

25 1 The Court has filed this Order under seal because it contains material subject to sealing orders.

Within seven days of the filing date of this Order, the Parties shall provide the Court a stipulated

26 redacted version of this Order, redacting only those portions of the Order containing or referring to

material for which the Court has granted a motion to seal and for which the Parties still request the

27 material be sealed. The Court will then issue a redacted version of the Order.

Case No.: 5:18-cv-02352-EJD

1 Defendant’s operating systems—IOS, IOS XE, IOS XR, or NX-OS (“the Accused Operating

2 Systems”)—of infringing the Patents-in-Suit. Those features (“the Accused Features”) are the

3 Embedded Event Manager (“EEM”), Control Plane Policing (“CoPP”), Local Packet Transport

4 Services (“LPTS”), and Excessive Punt Flow Trap (“EPFT”). EEM is included in all four Cisco

5 network operating systems, CoPP is included in three (IOS, IOS XE, and NX-OS), and LPTS and

6 EPFT are included in one (IOS XR).

7 Defendant hired Dr. Kevin Almeroth, a computer-networking expert, to serve as

8 Defendant’s designated expert on invalidity. Plaintiff retained Dr. Aviel Rubin, a computer

9 security expert, to opine about the importance of the technology in the asserted claims, how that

10 technology contributed to the value of Plaintiff’s software, and how that technology currently

11 contributes to the value of the Accused Features. Plaintiff also retained Walter Bratic to provide

12 expert opinions on the damages owed to Plaintiff as a result of Defendant’s alleged infringement.

13 Several steps of Mr. Bratic’s apportionment analysis rely on Dr. Rubin’s technical opinions

14 concerning the Accused Feature and the Patents-in-Suit.

15 Each side has raised objections to part of the testimony of the others’ expert witnesses

16 based on either a Federal Rule of Civil Procedure 26 or Federal Rule of Evidence 702, including

17 the principles set out in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). The

18 Court addresses these arguments below.

19 B. Procedural History

20 On January 16, 2020, Plaintiff filed a motion to strike portions of Defendant’s expert

21 report and exclude related testimony. Plaintiff NetFuel Inc.’s Notice of Motion and Motion to

22 Strike (“P Mot.”), Dkt. 255-3. Defendant file an opposition on January 30, 2020. Defendant

23 Cisco Systems, Inc.’s Opposition to NetFuel’s Motion to Strike (“D Opp.”), Dkt. 275-4. On

24 February 6, 2020, Plaintiff filed a reply. NetFuel’s Reply in Support of its Motion to Strike (“P

25 Reply”), Dkt. 284-4.

26 On January 16, 2020, Defendant filed a motion to strike portions of Plaintiff’s expert

27

Case No.: 5:18-cv-02352-EJD

1 report and exclude related testimony. Defendant Cisco Systems, Inc.’s Motion to Exclude (“D

2 Mot.”), Dkt. 257-4. Plaintiff filed an opposition on January 30, 2020. NetFuel’s Opposition to

3 Cisco’s Motion to Exclude (“P Opp.”), Dkt. 274-4. On February 6, 2020, Plaintiff filed a reply.

4 Defendant Cisco Systems, Inc.’s Reply in Support of Cisco’s Motion to Exclude (“D Reply”),

5 Dkt. 286.

6 II. LEGAL STANDARDS

7 A. Federal Rule of Civil Procedure 26

8 Federal Rule of Civil Procedure 26(a)(2)(B) requires that a party seeking to offer expert

9 witness testimony at trial disclose a “written report—prepared and signed by the witness.” This

10 rule, however, does not “preclude counsel from providing assistance to experts in preparing the

11 reports.” Fed. R. Civ. P. 26(a)(2)(B) advisory committee’s note to 1993 amendment; but see

12 Bekaert Corp. v. City of Dyersburg, 256 F.R.D. 573, 578 (W.D. Tenn. 2009) (“[T]he expert must

13 substantially participate in the preparation of his report.”). “Determining whether counsel crosses

14 the line separating permissible assistance from improper participation in the expert’s report writing

15 calls for a ‘fact-specific inquiry.’” Optronic Techs., Inc. v. Ningbo Sunny Elec. Co., Ltd., 2019

16 WL 4780183, at *2 (N.D. Cal. Sept. 30, 2019) (quoting Numatics, Inc. v. Balluff, Inc., 66 F. Supp.

17 3d 934, 942 (E.D. Mich. 2014)). The key question is “whether counsel’s participation so exceeds

18 the bounds of legitimate assistance as to negate the possibility that the expert actually prepared his

19 own report.” Bekaert, 256 F.R.D. at 578. Additionally, if the “opinions expressed in an expert

20 report are not the opinions of the expert, the expert will not be able to satisfy the requirements of

21 [Rule 702] . . . that the report be based on the expert’s own valid reasoning and methodology.”

22 Trigon Ins. Co. v. United States, 204 F.R.D. 277, 294 (E.D. Va. 2001) (citing Fed. R. Evid. 702).

23 B. Federal Rule of Evidence 702

24 Federal Rule of Evidence 702 provides that once an expert has been qualified on their

25 “knowledge, skill, experience, training, or education,” they may testify as to their opinions if:

26 (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact

27

Case No.: 5:18-cv-02352-EJD

1 to understand the evidence or to determine a fact in issue;

2 (b) the testimony is based on sufficient facts or data;

3 (c) the testimony is the product of reliable principles and methods; and

4 (d) the expert has reliably applied the principles and methods to the facts of the case.

5 When considering motions to exclude expert testimony, the trial court “acts as a

6 gatekeeper” by “making a preliminary determination that the expert’s testimony is reliable.”

7 Optronic Techs., Inc., 2019 WL 4780183 at *1; see also Oxford Gene Tech. Ltd. v. Mergen Ltd.,

8 345 F. Supp. 2d 431, 433 (D. Del. 2004) (“Motions to exclude evidence are committed to the

9 court’s discretion.”). Rule 702 and Daubert are not “guarantees of correctness;” rather, they are

10 safeguards against unreliable or irrelevant expert opinions. i4i Ltd. P’ship v. Microsoft Corp., 598

11 F.3d 831, 855 (Fed. Cir. 2010). Daubert thus tests “the soundness of [the expert’s] methodology.”

12 Primiano v. Cook, 598 F.3d 558, 564–65 (9th Cir. 2010) (“Under Daubert, the district judge is ‘a

13 gatekeeper, not a fact finder.’”).

14 The Federal Circuit2 has condemned the use of arbitrary, “plucked out of thin air”

15 percentages in damages apportionment analyses. LaserDynamics, Inc. v. Quanta Comput., Inc.,

16 694 F.3d 51, 69 (Fed. Cir. 2012). “Experts must follow some discernable methodology, and may

17 not be a black box into which data is fed at one end and from which an answer emerges at the

18 other.” GPNE Corp. v. Apple, Inc., 2014 WL 1494247, at *4 (N.D. Cal. Apr. 16, 2014) (quotation

19 marks and citation omitted). So long as an opinion is “premised on reliable scientific principles, it

20 should not be excluded by the trial judge.” In re Roundup Prods. Liab. Litig., 390 F. Supp. 3d

21 1102, 1109 (N.D. Cal. 2018).

22

23 2 Plaintiff contends that “Ninth Circuit law governs the admission of expert testimony.” P Opp. at

5. While it is true that Ninth Circuit law governs the admissibility of expert testimony generally,

24 when a Daubert motion raises patent-specific damages issues, district courts must use Federal

Circuit precedent. See, e.g., Wordtech Sys., Inc. v. Integrated Networks Sols., Inc., 609 F.3d 1308,

25 1318 (Fed. Cir. 2010) (“When reviewing damages in patent cases, we apply regional circuit law to

procedural issues and Federal Circuit law to substantive and procedural issues ‘pertaining to patent

26 law.’” (citation omitted)). This Court thus uses Federal Circuit, and not Ninth Circuit, precedent

when reviewing Plaintiff’s experts’ damage calculations. Cf. P Opp. at 1 (arguing this Court must

27 apply Ninth Circuit law).

Case No.: 5:18-cv-02352-EJD

1 III. DISCUSSION

2 A. Plaintiff’s Motion to Exclude Portions of Dr. Almeroth’s Expert Report

3 As noted above, Defendant retained Dr. Almeroth to offer an opinion as to whether the

4 Patents-in-Suit are invalid. See Opening Expert Report of Dr. Kevin C. Almeroth of Invalidity of

5 U.S. Patent Nos. 7,747,730 and 9,663,659 (“Almeroth Report”), Dkt. 255-5. Plaintiff challenges

6 portions of the report on the grounds that (1) Dr. Almeroth did not author his own opinions on

7 anticipation and obviousness for 21 out of 25 primary prior-art references and (2) Dr, Almeroth’s

8 opinions about anticipation and obviousness are so conclusory and lacking in analysis that they are

9 unreliable and thus unhelpful to the jury. P Mot. at 4. The Court addresses each argument in turn.

10 1. Ghost-Writing

11 Plaintiff first argues that Dr. Almeroth’s report must be excluded pursuant to Federal Rule

12 of Civil Procedure 26(a)(2)(B) because the portions sought to be struck were “ghost-written.” Id.

13 at 5. There is no dispute that Dr. Almeroth’s report relies on, and at some points recites verbatim,

14 Defendant’s initial invalidity contentions. See D Opp. at 7. Plaintiff contends that Dr. Almeroth

15 did not write or assist in writing these invalidity contentions. P Mot. at 13. Thus, in Plaintiff’s

16 view, because Dr. Almeroth did not write the initial invalidity contentions recited in his invalidity

17 report, the Court must strike portions of the report that recite the initial invalidity contentions. Id.

18 at 12.

19 Plaintiff’s argument, however, is flawed. It ignores the reality that Federal Rule of Civil

20 Procedure 26 does not require experts to unilaterally write their reports. Indeed, attorneys may be

21 involved in the preparation of an expert report. Manning v. Crockett, 1999 WL 342715, at *3

22 (N.D. Ill. May 18, 1999) (noting that an expert need only “substantially participate” in the

23 preparation of a report). This involvement can include “counsel’s paraphrasing of the expert’s

24 qualifications, counsel’s providing ‘teamwork,’ ‘collaboration,’ or editorial assistance on the

25 report, counsel’s composing of initial drafts of reports based upon communications with the expert

26 and allowing the expert to substantively revise the report to reflect the expert’s opinions, or

27

Case No.: 5:18-cv-02352-EJD

1 counsel’s drafting of the report with the expert’s substantive assistance.” Accentra Inc. v. Staples,

2 Inc., 2010 WL 11459205, at *4 (C.D. Cal. Oct. 7, 2010) (collecting cases). For instance, in

3 Numatics, the court excluded the expert’s report because counsel wrote the entire report and the

4 expert only made “fairly minor” changes before signing it. 66 F. Supp. 3d at 944 (noting that the

5 expert “conceded” at his deposition that he did not draft his report). Thus, there, the report did not

6 represent the expert’s own commentary on the evidence and was, in fact, “several degrees

7 removed from his own work.” Id.

8 Unlike Numatics, counsel did not “ghost-write” Dr. Almeroth’s report. Dr. Almeroth not

9 only wrote a significant portion of his report, but also provided the information, analyses, and

10 opinions expressed in the report. First, during his deposition, Dr. Almeroth testified that he helped

11 draft the report and that the opinions therein are his own. See D Opp. at 12 (citing deposition

12 testimony); see also Icon-IP, 87 F. Supp. 3d at 950 (holding that even though counsel typed the

13 report, the expert still wrote the report since he testified that the information in the report came

14 from him); Accentra Inc., 2010 WL 11459205, at *5 (concluding that expert met Rule 26’s

15 requirements because her “testimony does not indicate that she had no involvement in the final

16 report); Optronics Techs., 2019 WL 4780183 at *2 (noting that expert testified that he reviewed

17 and edited the report and that the report captured his opinions and analysis); cf. Numatics, 66 F.

18 Supp. 3d at 944. Dr. Almeroth thus “substantially participated” in the preparation of the report.

19 Bekaert Corp., 256 F.R.D. at 578. This is confirmed by the fact that Dr. Almeroth spent over 100

20 hours between August 2019 and October 2019 working on his Opening Report and “provided

21 feedback on multiple drafts of the report before applying his signature.” D Opp. at 10; see also

22 Manning, 1999 WL 342715 at *3 (holding that an expert is not “substantially involved” in the

23 drafting of a report if the attorney simply drafts the report, without prior substantive input from the

24 expert, and then ask the expert to approve and sign the report).

25 Second, much like in Icon-IP, it is irrelevant that the “[claim] charts are similar to claim

26 charts prepared by counsel earlier in the litigation” because the charts “necessarily address the

27

Case No.: 5:18-cv-02352-EJD

1 same claims and prior art references.” 87 F. Supp. 3d at 943 (emphasis added). Finally, Dr.

2 Almeroth wrote a significant portion of his report. While Dr. Almeroth’s report recites

3 Defendant’s initial invalidity contentions, he does add analysis to the invalidity contentions.3 See

4 e.g., Dkt. 256-3. Accordingly, because Dr. Almeroth provided the information, analyses, and

5 opinions expressed in his report, the Court will not exclude his report or testimony. See Icon-IP,

6 87 F. Supp. 3d at 950; cf. Numatics, 66 F. Supp. 3d at 941 (excluding expert witness who served

7 as “lawyer’s avatar”).4

8 2. Reliability of Dr. Almeroth’s Opinions

9 Plaintiff next argues that Dr. Almeroth’s opinions on anticipation and obviousness are

10 unreliable and unhelpful to the trier of fact because they are “conclusory and unsupported.” P

11 Mot. at 16. Plaintiff contends that Dr. Almeroth never explains how the specific claim elements at

12 issue are to be understood and, based on that interpretation, how the claim elements are disclosed

13 or taught in the asserted prior art references. P Reply at 11. The Court disagrees.

14 Expert testimony is relevant if it assists the trier of fact in determining the case. Daubert v.

15 Merrell Dow Pharm., Inc., 509 U.S. 579, 590–95 (1993). “It is well-established that the first step

16 in any validity analysis is to construe the claims of the invention to determine the subject matter

17 for which patent protection is sought.” Smiths Indus. Med. Sys., Inc. v. Vital Signs, Inc., 183 F.3d

18 1347, 1353 (Fed. Cir. 1999) (citation omitted). Hence, in order for an expert’s report to be

19 relevant, it must explain how the expert understands the specific claim elements at issue. Oxford

20 Gene Technology is instructive. In Oxford Gene, the court excluded the invalidity expert’s report

21 pursuant to Federal Rule of Evidence 702 because the expert “fail[ed] to disclose a clear

22

23 3 Notably, Dr. Almeroth did spend four hours assisting Defendant with these initial invalidity

contentions. P Mot. at 10.

24 4 In the alternative to Federal Rule of Civil Procedure 26, Plaintiff argues Dr. Almeroth’s “ghost-

written” report should be excluded under Federal Rule of Evidence 703. This argument, however,

25 depends on the Court concluding that Dr. Almeroth did not prepare his report. As established

above, the Court has held to the contrary. See supra. Thus, because the “opinions expressed in

26 [the] expert report are . . . the opinions of [Dr. Almonte],” the requirements of Rule 702 are

satisfied since the “report [is] based on [Dr. Almonte’s] own valid reasoning and methodology.”

27 Trigon Ins., 204 F.R.D. at 294.

Case No.: 5:18-cv-02352-EJD

1 construction of each disputed claim element,” which made his report “less than helpful to the trier

2 of fact.” 345 F. Supp. 2d at 436. The expert only “appl[ied] a negative or alternative construction

3 of the claims . . . and [made] blanket conclusions of invalidity based on ‘anticipation and/or

4 obviousness,’ [after] assuming the court found that such construction did not apply.” Id.

5 Unlike the expert in Oxford Gene, Dr. Almeroth did not “ignore[] this fundamental first

6 step.” Id. at 435. Dr. Almeroth’s report contains a detailed “Claim Construction” chart and

7 language that indicates that Dr. Almeroth’s opinions are based on these constructions. See Dkt.

8 255-5 at 17–19. He confirms this in his deposition testimony. See D Opp. at 23 (“[My report]

9 talks about the different claim scopes based on plain and ordinary meaning and the court’s

10 constructions. NetFuel’s infringement contentions. And then in the reply report, Dr. Rubin’s

11 infringement report.”); cf. Oxford Gene, 345 F. Supp. 2d at 435 (noting that the expert did not set

12 out his claim construction “in a separate section” of his report).

13 Plaintiff argues in response that even while this is true, the report is flawed because Dr.

14 Almeroth never indicates whether he is relying on the Court’s construction, his own

15 understanding, or his interpretation of how Plaintiff understands the terms. P Reply at 12.

16 Instead, Plaintiff contends, the report simply states at the outset of each section that the reference

17 “anticipates and renders obvious the claims . . . at least under the apparent application of the

18 claims in NetFuel’s infringement contentions.” Id. at 12 (citing Dr. Almeroth report) (emphasis

19 omitted). This, in Plaintiff’s view, is fatal because it shows that Dr. Almeroth failed to disclose

20 what interpretation he is applying when analyzing the prior art. Id. at 13.

21 The Court, again, disagrees. First, the claim construction section of the report clearly

22 identifies how Dr. Almeroth construes certain claim terms. See Dkt. 255-5 at 17–19. Second, for

23 terms that this Court has not defined, Dr. Almeroth explains that his interpretation of claim terms

24 and prior art is based “at least under the apparent application of the claims in NetFuel’s

25 infringement contentions.” See, e.g., id. at 19. Dr. Almeroth thus uses the same claim elements as

26 Plaintiff. And, despite Plaintiff’s statements to the contrary, Dr. Almeroth need not commit to one

27

Case No.: 5:18-cv-02352-EJD

1 interpretation. It is permissible for him to qualify claim terms with expressions like “at least.”

2 Compare Stryker Corp. v. Zimmer, Inc., 837 F.3d 1268, 1276 n.4 (Fed. Cir. 2016) (“[N]othing

3 precludes Zimmer from arguing for a narrower application of the limitation on the infringement

4 context, while also arguing, in the alternative, that . . . the patent claim would be so broad as to be

5 invalid.”), with P Reply at 12 (“Cisco cannot avoid the fact that not once in his entire report does

6 Dr. Almeroth state which interpretation of a given claim term he is using, let alone indicate

7 whether he is relying on the Court’s construction, his own . . . [or] how he believes NetFuel

8 understands each term in light of NetFuel’s contentions.”). Thus, much like in Icon-IP, Dr.

9 Almeroth’s expert report is permissible because “he assumes that [Plaintiff’s] understanding of the

10 construed claims is correct, and then proceeds to demonstrate how, in his opinion, each element of

11 the claim[] is found in the prior art.” 87 F. Supp. 3d at 943; cf. TruePosition, Inc. v. Andrew

12 Corp., 2007 WL 2429415, at *1 (D. Del. Aug. 23, 2007) (holding expert could not rely on broad

13 interpretation because he failed to include in his invalidity report how the defendant’s equipment

14 compares to either the claim limitations or the prior art).

15 The Court also disagrees with Plaintiff’s position that Dr. Almeroth’s report is conclusory

16 and lacking in analysis. P Mot. at 18. “The second step in evaluating the validity of a patent is to

17 perform an element-by-element comparison of each claim to each prior reference.” Oxford Gene,

18 345 F. Supp. 2d at 436. Dr. Almeroth performs such an element-by-element analysis. For

19 instance, in his report, on page 25 of the report, Dr. Almeroth explains why the prior art discloses

20 an element of claim 1. See Dkt. 255-5 at 25; compare id. at 370–71 (comparing claims of the ’659

21 patent to prior art and then analyzing why a person of ordinary skill in the art would have been

22 motivated to combine the prior art), with Elder v. Tanner, 205 F.R.D. 190, 194 (E.D. Tex. 2001)

23 (holding expert’s opinions about infringement, anticipation, and obviousness were too conclusory

24 because the report simply listed the resources used and then stated an ultimate opinion without

25 discussing the expert’s thought process), and Innogenetics, N.V. v. Abbott Labs., 512 F.3d 1363,

26 1373 (Fed. Cir. 2008) (same). Dr. Almeroth thus explains “in detail how each claim element is

27

Case No.: 5:18-cv-02352-EJD

1 disclosed in the prior art reference.” Finjan, Inc. v. Blue Coat Sys., LLC, 283 F. Supp. 3d 839, 855

2 (N.D. Cal. 2017); see also In re Kahn, 441 F.3d 977, 988 (Fed. Cir. 2006) (“[T]here must be some

3 articulated reasoning with some rational underpinnings to support the legal conclusion of

4 obviousness.”).

5 Moreover, courts have found that “claim charts appended to [expert] reports are

6 sufficiently detailed . . . to establish that [the] opinions will be helpful to the jury.” Icon-IP Pty

7 Ltd., 87 F. Supp. at 943. As Dr. Almeroth notes on page 34 of his report, Exhibit B-3 attached to

8 the report contains such claim charts. Accordingly, Dr. Almeroth’s opinions are not conclusory

9 and are permissible under Federal Rule of Evidence 703 and Federal Rule of Civil Procedure

10 26(a). For the foregoing reasons, Plaintiff’s motion to strike portions of Dr. Almeroth’s testimony

11 is DENIED.

12 B. Defendant’s Motion to Exclude Portions of Mr. Bratic’s and Dr. Rubin’s

13 Expert Reports

14 Mr. Bratic used two methods to calculate damages—an apportioned profit theory and a

15 per-unit royalty theory. Dkt. 274-5 (“Bratic Report”) ¶ 206. Defendant argues both theories must

16 be excluded because each is “based on vague, qualitative notions that lack underlying support or

17 methodology” in contravention of Daubert. D Mot. at 1–2. The Court addresses each damage

18 theory in turn.

19 1. Apportioned Profits

20 Mr. Bratic calculated a royalty based on a percentage of Defendant’s alleged gross

21 revenues. Bratic Report ¶ 174. To calculate this percentage, Mr. Bratic took the gross revenues

22 from the Accused Devices and then applied a series of apportionments to arrive at a 2.1%

23 apportionment rate. See id. ¶ 212 (“[N]o less than approximately 2% of Cisco’s sales and profits

24 of [the] Accused Devices are attributable to the Patents-in-Suit.”); see also P Opp. at 2 (“The

25 Accused Devices are fifteen families of Cisco routers and switches that run one of [the Accused

26 Operating Systems].”). Defendant takes issue with the following three apportionments:

27

Case No.: 5:18-cv-02352-EJD

1  Apportionment of 33% for the profits allegedly representing the “contribution of security,

2 reliability, and availability” to the Accused Operating Systems.

3  Apportionment of 33% and 50% for the alleged contributions of the Accused Features to

4 the value of all security, reliability, and availability on the Accused Devices.

5  Apportionment of 70% and 40% for the portions of the Accused Features that are allegedly

6 attributable to the Patents-in-Suit.

7 Defendant argues that these adjustments are unsupported and thus must be excluded. D Mot. at 7–

8 8. The Court analyzes each apportionment below.

9 a. Apportioning Security, Reliability, and Availability of Accused

10 Operating Systems

11 Mr. Bratic estimated that “security, reliability, and availability” represented 33% of the

12 value of the Accused Operating Systems. Bratic Report ¶ 198. Mr. Bratic relied on Dr. Rubin’s

13 analysis for this apportionment step.5 Id. Plaintiff argues that this opinion is reliable because, in

14 reaching this conclusion, Dr. Rubin considered: (1) industry research (including Defendant’s own

15 statements concerning the security, reliability, and availability of the Accused Operating Systems);

16 (2) his knowledge and understanding of the Accused Devices (gained by his review of Cisco-

17 produced technical documents and his testing of the Accused Devices); (3) his knowledge and

18 understanding of Defendant’s networking operating systems (gained by his extensive review of

19 Cisco-produced technical documents and by his review of Cisco operating system source code);

20 (4) his experience and specialized expertise in computer networking and security; and (5) his

21 expert knowledge of the nature and function of routers and switches. P Opp. at 19 (citing Dkt.

22 274-10 [“Rubin Report”] ¶¶ 45–86, 230–72, 360–61, 384–386); see also Dkt. 274-11 (“Rubin

23 Reply Report”) ¶ 133–36.

24

25 5 The Parties do not dispute that Mr. Bratic “relie[d] on a technical expert, Dr. Rubin, for this

apportionment step.” P Opp. at 18; see also Dkt. 257-9 (“Rubin Depo.”) at 208 (“I don’t know the

26 specifics of how [Dr. Rubin] arrived at 33% . . . .”). Thus, because Mr. Bratic’s analysis depends

on the validity of Dr. Rubin’s analysis, in order for Mr. Bratic’s analysis to stand, Dr. Rubin’s

27 figure must be “reliable.”

Case No.: 5:18-cv-02352-EJD

1 As discussed above, an expert witness must follow some discernable methodology, and

2 may not be a “a black box into which data is fed at one end and from which an answer emerges at

3 the other.” GPNE Corp., 2014 WL 1494247 at *4. In order for this Court to determine whether

4 Dr. Rubin’s conclusions are “reliable” and based on “sufficient facts or data,” the Court must be

5 able to follow his methodology. See Fed. R. Evid. 702. Indeed, “nothing in either Daubert or the

6 Federal Rules of Evidence requires a district court to admit opinion evidence that is connected to

7 existing data only by the ipse dixit of the expert. A court may conclude that there is simply too

8 great an analytical gap between the data and the opinion proffered.” Gen. Elec. Co. v. Joiner, 522

9 U.S. 136, 146 (1997). While the Federal Circuit allows for “some approximation” in the

10 reasonable royalty context, this “does not negate the Federal Circuit's requirement of ‘sound

11 economic and factual predicates’ for that analysis.” Cornell Univ. v. Hewlett-Packard Co., 2008

12 WL 2222189, at *2 (N.D.N.Y. May 27, 2008) (quoting Riles v. Shell Expl. & Prod. Co., 298 F.3d

13 1302, 1311 (Fed. Cir. 2202).

14 After reviewing Dr. Rubin’s reports, the Court agrees with Defendant—Dr. Rubin’s

15 conclusion that “security, reliability, and availability” represented 33% of the value of the

16 Accused Operating Systems is an impermissible black box without “sound economic and factual

17 predicates.” Riles, 298 F.3d at 1311. In his opening report, Dr. Rubin cursorily determined that

18 the security, reliability, and availability represent at least 33% of the Accused Operating System.

19 See Rubin Report ¶ 386. This determination is made based on Dr. Rubin’s “experience in

20 computer network and security,” “[his] knowledge of the nature and function of routers and

21 switches,” and “[his] knowledge and understanding of the Accused Products and Cisco’s network

22 operating systems.” Id.; but see GPNE Corp., 2014 WL 1494247 at *5 (noting that “experience”

23 does not constitute “sufficient facts or data” or “reliable principles and methods”). Dr. Rubin

24 further declares that “[s]ecurity, reliability, and availability are extremely important to the network

25 operating systems that run on network routers and switches.” Id. ¶ 384; see also id. ¶ 385. But,

26 using industry-wide data as a starting point is improper. See Open Text S.A. v. Box, Inc., 2015 WL

27

Case No.: 5:18-cv-02352-EJD

1 349197, at *6 (N.D. Cal. Jan. 23, 2015) (“[D]ecisions from the Federal Circuit and this district

2 have rejected deriving a royalty rate by picking a starting point based on industry-wide data (rather

3 than facts specific to the case at hand) and varying it upwards or downwards using the Georgia–

4 Pacific and other factors.”).

5 Moreover, to the extent Dr. Rubin bases his industry research on Cisco statements, he

6 never explains how those statements weighed in his 33% evaluation. See, e.g., Rubin Report

7 ¶ 385 (stating that various technical documents published by Defendant confirm the importance of

8 security, reliability, and availability); Rubin Reply Report ¶¶ 133–34 (same). This is fatal; without

9 explaining how he arrived at “33%,” the figure appears to have been “plucked out of thin air based

10 on vague qualitative notions of the relative importance of [security, reliability, and availability to

11 Defendant].” LaserDynamics, 694 F.3d at 69. As Dr. Rubin confirmed in his deposition, neither

12 his opening nor reply report explain the features that comprise the 67% of remaining value. Dkt.

13 257-12 (“Rubin Depo.”), at 248.

14 The complete lack of economic analysis to support Dr. Rubin’s apportionment “echoes the

15 kind of arbitrariness of the ‘25% Rule’ that [the Federal Circuit] recently and emphatically

16 rejected from damages experts.” Id. In an attempt to evade LaserDynamics, Plaintiff argues that

17 Defendant invents a new legal standard by seeking to impose a “quantitative analysis” requirement

18 based “on a single word mentioned in dicta by a Federal Circuit opinion applying Fifth Circuit law

19 concerning an entirely different concept.” P Opp. at 6. Not so. First, as established, Federal

20 Circuit law applies to a Daubert motion with patent-specific damages issues. See, e.g., Wordtech

21 Sys., 609 F.3d at 1318; see also supra n.2. Thus, LaserDynamics, which addressed a patent-

22 specific damages issue, controls this Court’s analysis. Second, contrary to Plaintiff’s position,

23 LaserDynamics’ requirement of quantitative support for apportionments is not limited to a specific

24 theory of damages. See 694 F.3d at 69 (stating that the lack of quantitative support would “alone

25 justify” excluding the expert’s opinions at trial). Third, the requirement of quantitative support

26 follows the requirement that percentages not be “plucked out of thin air.” Fourth, contrary to

27

Case No.: 5:18-cv-02352-EJD

1 Plaintiff’s contention that cross-examination and presentation of contrary evidence is the proper

2 means to attack Dr. Rubin’s opinion, cross-examination cannot cure the deficiencies in Dr.

3 Rubin’s analysis. See GPNE Corp., 2014 WL 1494247 at *6 (“Without a methodology . . . cross-

4 examination is futile.”); see also id. (holding that cross-examination was futile because it the

5 expert’s opinion rested on his experience and his “numerous statements that 3G and 4G LTE

6 technology is valuable”). Accordingly, because Dr. Rubin failed to provide the methodology

7 underlying his apportionment amount or explain how he arrived at that figure based on the facts of

8 this case, his apportionment opinion is not backed by “sufficient facts or data” or by “reliable

9 principles and methods” and so his 33% apportionment, and all opinions relying on the figure,

10 must be excluded.

11 b. Apportioning Security, Reliability, and Availability of Accused

12 Features

13 Mr. Bratic’s next revenue apportionment step relied on two opinions offered by Dr. Rubin:

14 (1) that 33% of the value of “security, reliability, and availability” of Cisco’s IOS-XR operating

15 system is allegedly attributable to the Accused EPFT Feature and (2) that 50% of the value of the

16 “security, reliability, and availability” of Cisco’s IOS, IOS-XE, IOS-XR, and NX-OS operating

17 systems is allegedly attributable to the Accused Combination of EEM and either CoPP or LPTS.6

18 See P Opp. at 19–20 (citing Rubin Report ¶ 388). Plaintiff argues that these opinions are reliable

19 because, in reaching this conclusion, Dr. Rubin considered: (1) his knowledge and understanding

20 of the Accused Devices (gained by his review of Cisco-produced technical documents and his

21 testing of the Accused Devices); (2) his knowledge and understanding of Defendant’s networking

22 operating systems (gained by his extensive review of Cisco-produced technical documents and by

23 his review of Cisco operating system source code); (3) the analysis and opinions described in his

24

25 6 Again, the Parties do not dispute that Mr. Bratic “relie[d] on Dr. Rubin’s expert opinion for this

apportionment step.” P Opp. at 19; see also Rubin Depo. at 209–10, 214 (stating that Dr. Rubin

26 did not provide any quantitative analysis to support his figures). Thus, because Mr. Bratic’s

analysis depends on the validity of Dr. Rubin’s analysis, in order for Mr. Bratic’s analysis to

27 stand, Dr. Rubin’s figure must be “reliable.”

Case No.: 5:18-cv-02352-EJD

1 report concerning the Accused Devices and the Accused Features (including his thorough analyses

2 of the Accused Features’ functionality and implementation); and (4) his experience and

3 specialized expertise in computer networking and security. Id. (citing Rubin Report ¶¶ 45–86,

4 230–72, 360–61, 388; Rubin Reply ¶ 134).

5 Similar to the Court’s holding above, see supra III.B.1.a., Dr. Rubin’s “33%” and “50%”

6 findings lack “sound economic and factual predicates.” Riles, 298 F.3d at 1311. In his opening

7 report, Dr. Rubin again relies on his “experience” and vague notions about the Accused Features

8 contribution to the “security, reliability, and availability of the Accused Devices.” See Rubin

9 Report ¶¶ 387–88. For instance, he claims, without support, that EPFT “ensures availability and

10 reliability of the device” and that the combinations of EEM and CoPP or LPTS provide a “higher

11 contribution” to the security, reliability, and availability of the Accused Devices than EPFT. Id.

12 ¶ 387. Yet, Dr. Rubin fails to explain how the combination of EEM and CoPP or LPTS provided

13 such “higher contribution.” Such vague, qualitative descriptions, without some indication as to

14 the weight or value attributed to each feature, are insufficient to support Dr. Rubin’s specific

15 apportionment conclusions. Cf. LaserDynamics, 694 F.3d at 69 (requiring some economic

16 analysis to support the apportionment).

17 Dr. Rubin’s Reply Report does not cure the deficiencies in his opening report. See Rubin

18 Reply Report ¶ 135. There, Dr. Rubin analyzes the Accused Features’ importance individually

19 and notes that:

20  Defendant’s employees have called CoPP “critical to network operation,” “essential in

21 order to protect the CPU,” and stated that, without CoPP, Cisco “cannot protect the switch

22 against DoS attacks.”

23  Defendant’s employees have described LPTS as “[e]quivalent to CoPP but MUCH better,”

24 and said that “LPTS is not a feature! It has to be there otherwise the router would not work

25 at all.” LPTS is “a basic functionality required in the box for it to function.”

26  EEM has been called a “big powerful tool to diagnose problems” and “has been a

27

Case No.: 5:18-cv-02352-EJD

1 differentiating feature that helped enable many sales opportunities in a competitive

2 situation.”

3  EPFT is a necessary feature because it helps “maintain a ‘fair share’ of control packets sent

4 by various devices and stop[s] bad actors from hogging the control packets sent to the

5 LPTS/CPU of the router.” It is a “must have feature” in Defendant’s eyes and a

6 “mandatory requirement.”

7 But, apart from EPFT, the Accused Features do not infringe based on their individual

8 functionality—they must be used in a specific combination to infringe.7 See Order Denying

9 Cisco’s Motion for Summary Judgment at 2, Dkt. 283. Dr. Rubin does not explain how this

10 information, about individual features, supports his conclusion as to the apportionment of 50% for

11 the Accused Combination of EEM and CoPP/LPTS. Moreover, Dr. Rubin does not explain how

12 the above information about EPFT factors into his 33% evaluation See LaserDynamics, 694 F.3d

13 at 69 (finding that the lack of quantitative economic analysis to support the expert’s

14 apportionment echoes the type of arbitrariness that the Federal Circuit has rejected).

15 Plaintiff argues that Dr. Almeroth, Defendant’s damages expert, similarly “offers bare

16 opinions” and thus that this is nothing more than “experts’ disagreement concerning the relative

17 value of the Accused Features.” P Opp. at 21. The Court disagrees. As stated above, in order for

18 an expert’s opinion to be admissible, there must be a proper factual basis for the opinion. See

19 Finjan, 2015 WL 4272870, at *4. Hypothesized damages, not grounded in fact, are not

20 admissible. Id.; see also LaserDynamics, 694 F.3d at 69. Moreover, Dr. Almeroth’s opinion and

21 apportionment rates are not “pulled out of thin air.” To the contrary, Dr. Almeroth explains the

22 facts underlying his apportionment percentages, how they connect to his apportionment

23 percentages, and the methodology he used to arrive at his apportionment percentages. See Dkt.

24 274-13 at ¶¶ 388–91 (explaining the number of possible combinations and how they are

25

26 7 Defendant argues Mr. Bratic’s analysis fails to account for the fact that customers rarely use the

accused features in the specific combination needed to infringe. The Court does not reach this

27 argument as it holds that the percentages lack support.

Case No.: 5:18-cv-02352-EJD

1 attributable to the accused functionality of the asserted patents). Accordingly, because Dr. Rubin

2 failed to provide the “methodology” underlying his apportionment amount or explain how he

3 arrived at that figure based on the facts of this case, his apportionment opinion is not backed by

4 “sufficient facts or data” or by “reliable principles and methods” and so his 33% EPFT and 50%

5 Accused Combination apportionments, and all opinions relying on the figures, must be excluded.

6 c. Apportioning the Accused Features for the Patents-in-Suit

7 Mr. Bratic next determined the portion of the Accused Features’ functionality attributable

8 to the asserted claims of the Patents-in-Suit. He relied on Dr. Rubin’s expert opinion to do this.8

9 In his report, Dr. Rubin opined that “at least 70%” of EPFT’s functionality and “at least 40%” of

10 the functionality provided by the combination of EEM + CoPP/LPTS is attributable to the asserted

11 claims of the Patents-in-Suit. See P Opp. at 21 (citing Rubin Report ¶ 389–90). Plaintiff argues

12 that these opinions are reliable. Dr. Rubin proceeds as follows: he first concludes that EPFT and

13 the combination of EEM + CoPP/LPTS infringe the asserted claims and thus include 100% of the

14 functionality recited in those claims. Rubin Report ¶ 389. Dr. Rubin next notes that both EPFT

15 and the combination of EEM + CoPP/LPTS include non-infringing functionality. Id. ¶¶ 389–90.

16 He then compares the relative value of the Accused Features’ infringing and non-infringing

17 functionalities. Id.; see also Rubin Reply Report ¶¶ 139–44.

18 For EPFT, Dr. Rubin noted that the feature’s primary function closely maps the asserted

19 patent claims, but that it can be configured to perform a non-infringing function. Specifically,

20 EPFT’s “only” non-infringing functionality is that it can be used “where a customer wants to

21 perform a dry run of EPFT before implementing it.” Rubin Report ¶ 389; Rubin Reply Report

22 ¶ 140. This, however, would “highly restrict[] the overall functionality of EPFT.” Rubin Reply

23 Report ¶ 140. Additionally, Defendant “advertises using EPFT’s full functionality.” Id. In light

24

25

8 Again, the Parties do not dispute that Mr. Bratic “relie[d] on Dr. Rubin’s expert opinion.” P

26 Opp. at 21; see also Rubin Depo. at 212 (stating that he simply adopted the numbers). Thus,

because Mr. Bratic’s analysis depends on the validity of Dr. Rubin’s analysis, in order for Mr.

27 Bratic’s analysis to stand, Dr. Rubin’s figure must be “reliable.”

Case No.: 5:18-cv-02352-EJD

1 of EPFT’s infringing and non-infringing functionality, Dr. Rubin attributed 70% of EPFT’s

2 functionality to patented functionality. Id. ¶ 139. This “under-estimated” the non-infringing

3 functionality to “err on the side of caution.” Id. ¶ 140.

4 For the combination of EEM + CoPP/LPTS, Dr. Rubin noted that the combination has

5 more non-infringing functionality than EPFT. Rubin Report ¶ 390. He listed the non-infringing

6 ways that EEM works with CoPP/LPTS. Id. Based on the non-infringing and infringing uses, Dr.

7 Rubin “conservatively” attributed at least 40% of the functionality provided by the combination of

8 EEM and CoPP or LPTS to the patented functionality. Id.; see also Rubin Reply Report ¶ 142.

9 These apportionment percentages suffer from the same problems analyzed above. Dr.

10 Rubin again failed to explain the methodology underlying his percentage calculations and again

11 relied on vague assertions about the Accused Feature’s value. See, e.g., Rubin Reply Report ¶ 139

12 (determining EPFT’s infringing functionality is “somewhat more than twice as valuable” as its

13 non-infringing functionality); Id. ¶ 144 (finding that EEM with CoPP or LPTS’s non-infringing

14 functionality “slightly outweighs” its infringing functionality); see also Open Text, 2015 WL

15 349197 at *5 (“[A] superficial recitation of the Georgia-Pacific factors, followed by conclusory

16 remarks is not enough.” (quotation marks and citation omitted); Whitserve, LLC v. Comput.

17 Packages, Inc., 694 F.3d 10, 31 (Fed. Cir. 2012) (“[W]hile mathematical precision is not required,

18 some explanation of both why and generally to what extent the particular factor impacts the royalty

19 calculation is needed.” (emphasis added)); TASER Int’l, Inc. v. Karbon Arms, LLC, 2013 WL

20 6773663, at *1 (D. Del. Dec. 19, 2013) (“[The expert] offers almost no basis as to how he arrived

21 at his royalty rate other than that he considered the above numbers and factors. This is the

22 quintessential ipse dixit justification.”).

23 Plaintiff argues that Dr. Rubin properly apportioned the value of the accused features by

24 “relative valuation.” P Opp. at 22. As support, Plaintiff cites to Mass Engineered Design, Inc. v.

25 Planar Systems, Inc., 2018 WL 6059375, at *1 (D. Or. Nov. 19, 2018). This case, however, does

26 not support Plaintiff’s position. While the Mass Engineered Design court denied the plaintiff’s

27

Case No.: 5:18-cv-02352-EJD

1 post-verdict motion to strike the expert declaration of Walter Bratic, the issues in Mass

2 Engineered Design are different from the issues present in this case. 2018 WL 6059375, at *1.

3 There, the defendant argued that Mr. Bratic failed to apportion damages to account for possible

4 non-infringement. Id. at *2. In contrast, here, the issue is not that Mr. Bratic (or Dr. Rubin) failed

5 to apportion non-infringing uses. Rather, the issue is whether the apportionment percentages are

6 properly supported. Cf. id. at *3 (noting that Mr. Bratic supported his apportionment rate because

7 he used technical weighing factors to apportion his royalty rate). Moreover, Mass Engineered

8 Design discussed a post-verdict royalty calculation, and so there was no need to exclude unreliable

9 expert testimony to protect the jury from being swayed by “dubious scientific testimony.” See id.

10 at *3 (“The challenged notions are not going to a jury.”).

11 Because Dr. Rubin failed to provide the “methodology” underlying his apportionment

12 amount or explain how he arrived at that figure based on the facts of this case, his apportionment

13 opinion is not backed by “sufficient facts or data” or by “reliable principles and methods” and so

14 his 70% EPFT and 40% Accused Combination apportionments, and all opinions relying on the

15 figures, must be excluded.

16 2. Per-Unit Royalty

17 Mr. Bratic also calculated a royalty rate of $120-per-unit based on two earlier transactions

18 where Plaintiff licensed PlexOS software to two banking institutions. Plaintiff alleges that PlexOS

19 “embodied the Patents-in-Suit.” P Opp. at 9; see also Rubin Report ¶ 381 (“Although Mr.

20 Harlow’s testimony and the documentary evidence I have reviewed are not sufficient for me to

21 form an opinion on whether PlexOS as implemented by NetFuel fully practiced the patents-in-suit,

22 the PlexOS technology is very closely related to the inventions disclosed in the patent.”).

23 Plaintiff licensed PlexOS twice. The first license was to Bank of America, which received

24 an implied license to PlexOS through a 2003 investment agreement and used PlexOS from 2004 to

25 2014. Dkt. 274-5 (“Bratic Report”) ¶¶ 135–36. Bank of America did not pay Plaintiff a cash

26 royalty for the license. Id. ¶ 136. The Bank did, however, provide Plaintiff important benefits

27

Case No.: 5:18-cv-02352-EJD

1 through the investment agreement, including an investment in NetFuel that made Bank of America

2 a minority owner in NetFuel. Id. The license also gave Plaintiff the chance to test and ruggedize

3 PlexOS in a commercial bank environment which was a “priceless” opportunity. Id.; see also Dkt.

4 276-8 (“Harlow Decl.”), at 106 (“[T]he value of having a large bank . . . providing us access to

5 infrastructure to install PlexOS on and run and use and abuse, that was priceless. Very few small

6 companies get a chance to do that.”). Ultimately, in 2014, Bank of America and Plaintiff reached

7 an impasse concerning the terms for the Bank’s continued use of PlexOS. Bank of America

8 wanted to use the service royalty-free, but Plaintiff insisted that the bank pay for a license.

9 Harlow Decl. at 107–08.

10

11 . See generally Dkt. 274-14 (“Settlement Agreement”).

12 The second PlexOS license was to BNP-Paribas. Bratic Report ¶ 137. In 2008, Bank of

13 America sold its prime brokerage business unit to BNP-Paribas. Id. In connection with this sale,

14 Bank of America purchased 244 PlexOS licenses that it then transferred to BNP-Paribas. Id.

15 Bank of America paid $1,000 per PlexOS license. Id. Additionally, Bank of America paid an

16 18% software maintenance fee. Thus, the sale resulted in total fees of $287,920 to Plaintiff. Id.

17 Based on these licenses (and other expert data), Mr. Bratic reached his offered rate of $120

18 per processor. To reach this rate, he applied two apportionment multipliers. First, he multiplied

19 the $1000-per-license fee that was paid in the BNP-Paribas Agreement by 20%. Id. ¶ 139 (basing

20 20% apportionment rate on statements of inventor of the Patents-in-Suit). Second, he multiplied

21 the $1000-per-license fee by 60%. Id. ¶ 144 (using 60% apportionment rate because of “Dr.

22 Rubin’s analysis). Defendant argues that Mr. Bratic’s per-unit royalty opinions should be

23 excluded because (1) his 20% reduction has no basis in fact, (2) his 60% reduction has no basis in

24 fact, and (3) he did not account for the severe differences in economic circumstances. The Court

25 addresses these arguments below.

26

27

Case No.: 5:18-cv-02352-EJD

1 a. 20% Reduction

2 In order to use the $1000 license fee as a basis for reasonable royalty damages, Mr. Bratic

3 needed to determine what portion of the fee was attributable to Plaintiff’s intellectual property.

4 See Bratic Report ¶ 139 (discussing Georgia-Pacific factor number 1). To answer this question,

5 Mr. Bratic used NetFuel’s determination that 80% of the license fee, or royalty, represented the

6 investment and time and effort to develop PlexOS and 20% represented the value of NetFuel’s

7 intellectual property. Id. The 20% figure came from NetFuel founders’, Bjorn Ahlblad and James

8 Harlow, determination “the 20% software maintenance fee initially agreed to by [Bank of

9 America] represented the recurring maintenance of the intellectual property in the PlexOS

10 software.” Id. Indeed, when asked how this 20% number was determined, Mr. Bratic testified:

11 [Jim Harlow] and [Bjorn Ahlblad] sat down and discussed how much

development effort went into developing the PlexOS product. And

12 they determined of that, 20% of the output, the work product,

associated with PlexOS was the intellectual property embodied in

13 PlexOS and 80% related to development—software development

efforts. And they decided that if they were going to charge a

14 maintenance fee, the maintenance fee would reflect a 20% of the—

the 20% reflecting the intellectual property portion of the

15 development efforts because the maintenance was to keep the

intellectual property updated.

16

Dkt. 257-9 (“Bratic Depo.”), at 128–29.

17

This analysis suffers from the same flaws discussed above—how did NetFuel’s founders

18

arrive at 20%? Why does the maintenance fee amount to 20%? Neither Mr. Bratic nor NetFuel’s

19

founders provide an explanation as to why the value of a “maintenance fee” is equivalent to the

20

value of the “market contribution of NetFuel’s intellectual property.” See P Opp. at 11–12.

21

Without any underlying “economic analysis to quantitatively support the [20%] apportionment,”

22

the figure is as good as “plucked out of thin air.” See LaserDynamics, Inc., 694 F.3d at 69; GPNE

23

Corp., 2014 WL 1494247 at *6. This case, much like GPNE Corp., involves an expert valuing a

24

royalty-rate based on “vague qualitative notions of the relative [value of the intellectual

25

property].” GPNE Corp., 2014 WL 1494247 at *6. Hence, contrary to Plaintiff’s argument,

26

cross-examination does not salvage Mr. Bratic’s opinion because his opinion is based on

27

Case No.: 5:18-cv-02352-EJD

1 NetFuel’s Founders’ arbitrary determination that 20% of the fee was attributable to Plaintiff’s

2 intellectual property. P Opp. at 12; cf. Fail-Safe, 744 F. Supp. 2d at 888 (“[T]he court cannot

3 simply take an expert’s word for a specific proposition.”). Accordingly, the 20% figure is

4 excluded.

5 b. 60% Reduction

6 For his second apportionment step, Mr. Bratic applied a percentage of 60% to the $1000-

7 per-license fee detailed above. Bratic Report ¶ 144. To justify this number, Mr. Bratic relied on

8 “Dr. Rubin’s analysis.” Id. Dr. Rubin told Mr. Bratic that “60% of the intellectual property in

9 PlexOS was comparable to the Patents-in-Suit.” Bratic Depo. ¶ 158. In his report, Dr. Rubin

10 stated:

11 Unlike the technology of the [] patents-in-suit, however, PlexOS is

highly extensible and is operable with functionality that extends

12 beyond what is claimed in the patents-in-suit, such as business

process automation and workflow management. NETFL00001805 p.

13 9 (describing workflow management with the following example:

“For example, . . . Tracy submits a paycheck request. Dave is then

14 notified on his blackberry and can either approve or deny the request.

Once approved, the request is queued in the payroll system.”).

15 PlexOS also provides agents and policies that extend beyond network

management and into the area of enterprise resource management. Id.

16 (“Custom agents engineered in-house or through a services

organization might embody custom business logic . . . .”). Based on

17 my analysis, I conclude that the patented inventions represent 60% of

the functionality or value of PlexOS.

18

Rubin Report ¶ 382 (emphasis added). In his Reply Report, Dr. Rubin similarly stated:

19

To reach my conclusion that the patented inventions represent 60%

20 of the functionality or value of PlexOS, I first reviewed the patents-

in-suit. Then I reviewed various documents and testimony describing

21 PlexOS and its functionality I note above. In my review, I noted that

PlexOS performed similar functions as the patented technology, but I

22 also observed that PlexOS has the option to be extended beyond the

limitations of the asserted patents to perform other tasks not related to

23 monitoring a computer network. I understand that clients actually

used PlexOS for these purposes. Based on all of my experience and

24 analysis, and the sources of information I have identified, and

because the main default use-case for PlexOS is captured by the

25 patents, I made the conservative determination that 60% of PlexOS

represents the patented technology. However, there are substantial

26 uses—which I concluded constitute 40% of the value of PlexOS—

that are not captured by the patents-in-suit.

27

Case No.: 5:18-cv-02352-EJD

1 Rubin Reply Report ¶ 124 (emphasis added).

2 Dr. Rubin’s analysis amounts to nothing more than plucking 60% out of thin air. See

3 LaserDynamics, 694 F.3d at 69; see also D Reply at 6 (noting that even while Mr. Bratic was

4 unable to determine if PlexOS as implemented by Plaintiff fully practiced the patents-in-suit, he

5 was able to determine that the patented inventions represented 60% of the value of PlexOS

6 intellectual property). He ascribes a value of 60% without providing an analysis as to why he

7 picked that percentage or the methodology behind the percentage. See GPNE Corp., 2014 WL

8 1494247 at *4–6 (noting that the failure to “follow [any] discernable methodology” is “classic ipse

9 dixit reasoning”).

10 Indeed, when pressed during his deposition, Dr. Rubin could not explain why he selected

11 60%. Rubin Depo. at 205 (“Well, the features that I saw that were in PlexOS that were not

12 covered by the patents-in-suit were a small number of features, and so 50 percent would not have

13 made sense because there was more than 50 percent attributable to the patents-in-suit.”). His

14 deposition answer, of course, begs the question, why not 59% or 62%? Notably, he “didn’t

15 perform a further analysis to see if it [sh]ould be a different number.” Id. at 215; see also id. at

16 205–06 (stating that he “didn’t provide a deep analysis” as to why the non-patented inventions

17 amounted to 40%). And, when asked how much value or weight he attributed to specific PlexOS

18 features, he admitted, “I didn’t specifically assign a weight or a value to any feature in—explicitly

19 in my report, but I did weigh them in my consideration by applying my familiarity with the

20 technology with the Patents-In-Suit and with PlexOS as part of my analysis.” Id. at 218. Mr.

21 Bratic’s generic descriptions of PlexOS’s features do not tie his 60% figure to the facts of the case

22 and, without appropriate support, the jury cannot weigh the value of his opinion. See GPNE

23 Corp., 2014 WL 1494247 at *6. Accordingly, the 60% figure is excluded.9

24

25 9 Plaintiff argues Defendant “invents” a new quantitative standard. P Opp. at 15–16; see also

supra III.B.1.a. Plaintiff misunderstands Defendant’s argument. The Federal Circuit and courts in

26 this district have made it clear that percentages may not be “plucked out of thin air.” The

complete absence of what methodology underlies Mr. Bratic and Dr. Rubin’s selection of

27 percentage values shows the figures are “arbitrary” and thus unreliable. Accordingly, it is

Case No.: 5:18-cv-02352-EJD

1 c. Accounting for Technological and Economic Differences

2 Defendant last argues that Mr. Bratic failed to account for the economic differences

3 between the licenses. D Reply at 7. Mr. Bratic used the royalties received by Plaintiff from

4 existing licenses as the basis for predicting the outcome of a hypothetical negotiation between the

5 Parties. As noted above, the licenses that Mr. Bratic based his analysis on involved PlexOS

6 software and not the Patents-in-Suit. See supra III.B.2.

7 Expert testimony based on license agreements “must provide a jury enough information to

8 “evaluat[e] the probative value of those agreements,” lest the jury be given “little more than a

9 recitation of royalty numbers” to determine the outcome of a particular hypothetical negotiation.

10 Apple, Inc. v. Samsung Elecs. Co., Ltd., 2014 WL 794328, at *8 (N.D. Cal. Feb. 25, 2014)

11 (quoting Lucent Techs., Inc. v. Gateway, Inc., 580 F.3d 1301, 1328–29 (Fed. Cir. 2009)). Thus,

12 under the first Georgia-Pacific factor, when relying on a transaction that involves “technologies

13 other than the patent in suit,” the expert “must account for ‘the technological and economic

14 differences’ between them.” ResQNet.com, Inc. v. Lansa, Inc., 594 F.3d 860, 869 (Fed. Cir.

15 2010); Wordtech Sys., Inc. v. Integrated Network Sols., Inc., 609 F.3d 1308, 1320 (Fed. Cir. 2010);

16 see also DataQuill Ltd. v. High Tech Comput. Corp., 887 F. Supp. 2d 999, 1023 (S.D. Cal. 2011)

17 (“[Plaintiff’s expert’s] report appears to have no analysis at all of the economic

18 differences . . . . Therefore, [the expert] has failed to establish economic comparability and his

19 testimony regarding the [prior] agreements should be excluded . . . .”).

20 Because the BNP transaction involves PlexOS, i.e. a technology that differs than the

21 Patents-in-Suit, the Court must decide whether Mr. Bratic properly accounted for the technological

22 and economic differences between the two licenses. Defendant argues that Mr. Bratic failed to

23 address how the following fundamental economic differences affect the royalty rate:

24 (1) The differences between the sale of a software license to use PlexOS and a non-exclusive

25

26

irrelevant that it is clear how the percentages are applied because it is unclear how those same

27 percentages were selected. See P Opp. at 16.

Case No.: 5:18-cv-02352-EJD

1 license to patents;

2 (2) The differences between licensing to Bank of America or BNP rather than Defendant, who,

3 in contrast to the banks, is a networking product company that licenses patents for the rights to

4 make, use, offer for sale, or import what the patent covers;

5 (3) The differences between licensing to companies who Plaintiff had pre-existing, ongoing

6 relationships with, and Defendant, who Plaintiff had no relationship with; and

7 (4) The differences between giving Bank of America an “implied license” to use PlexOS

8 software at no cost. D Mot. at 21–22.

9 Plaintiff contends that Mr. Bratic properly noted the “multiple differences” between the

10 PlexOS licensing scenario in his hypothetical negotiation and factored those differences into the

11 royalty rate. P Opp. at 14. The Court disagrees. After reviewing Mr. Bratic’s report (specifically

12 the paragraphs that Plaintiff directs the Court to), it is clear that even while Mr. Bratic notes the

13 differing circumstances, he never explains how the differences are reflected in his royalty rate.

14 See Bratic Report ¶¶ 135–45. Indeed, his only reductions are to account for the alleged value of

15 Plaintiff’s “intellectual property” (20%) and the portion of it that is “comparable to the patents-in-

16 suit” (60%). See id. ¶¶ 139, 144; see also supra (discussing those apportionment percentages).

17 This is confirmed by paragraph 145 of Mr. Bratic’s report, which states “Georgia-Pacific Factor

18 No. 1 indicates that the royalty rate per unit for a license to the Patents-in-Suit is $120 per single

19 processor.” Bratic Report ¶ 145. The $120 per processor figure was derived from multiplying the

20 $1000-per-license fee by 20% and 60%. See id. at 47 n.284. Thus, only the percentages, and not

21 the economic differences, were factored into the per-unit royalty calculation.

22 Accordingly, because Mr. Bratic failed to account for the “economic differences,” between

23 the BNP Agreement and the hypothetical license negotiation, he has not shown that the BNP

24 agreement is sufficiently comparable.10 ResQNet.com, Inc., 594 F.3d at 873. Without some

25

26 10 Defendant also argues that Mr. Bratic failed to address the technological differences between

PlexOS and the Patents-in-Suit. D Mot. at 22. The Court does not reach this argument as it finds

27 that Mr. Bratic failed to address the economic differences. See ResQNet.com, Inc., 594 F.3d at

Case No.: 5:18-cv-02352-EJD

1 showing that the economic differences were accounted for, Mr. Bratic’s use of the BNP agreement

2 to calculate his damages amount is “unreliable, irrelevant, and unhelpful to the jury’s task of

3 evaluating the result of the hypothetical negotiation.” Apple, Inc., 2014 WL 794328 at *11. The

4 Court thus excludes it.

5 C. Leave to Serve a Supplemental Damages Report

6 Plaintiff requests leave to serve a supplemental damages report to correct the deficiencies

7 identified in this Court’s order. The Court declines this request. Allowing a “second bite” can

8 encourage “overreaching on the first bite.” Network Prot. Sciences, LLC v. Fortinet, Inc., 2013

9 WL 5402089, at *8 (N.D. Cal. Sept. 26, 2013). A second bite is thus only appropriate where the

10 expert report can be salvaged with “minimal disruption to an orderly trial.” Id. Where, however,

11 the report is “not even close,” there is a need to deny a second bite so as to “encourage candor in

12 the first place. Id.; see also Unwired Planet, LLC v. Apple Inc., 2017 WL 589195, at *1 (N.D.

13 Cal. Feb. 14, 2017) (“But where the initial effort misses the mark so badly, it would be

14 inappropriate to incentivize overreaching by allowing a second attempt.”).

15 The Parties already have a trial date, which the Court and the Parties have built their

16 calendars around. Mr. Bratic and Dr. Rubin have had multiple opportunities to submit sufficient

17 testimony. Yet, they have failed to cure their deficient testimony. See Unwired Planet, 2017 WL

18 589195 at *1. Moreover, because of the sheer volume of deficiencies, Plaintiff would have to

19 advance new theories and methodologies. Defendant, who has already invested substantial time,

20 money, and effort into defending against Plaintiff’s experts, would be prejudiced by this. Not to

21 mention, Defendant’s expert already highlighted the deficiencies for Plaintiff’s experts, which

22 means Plaintiff’s experts submitted reply reports believing they cured any deficiencies. Plaintiff

23 failed to cure its own overreaching and will not be allowed a second bite at the apple. Network

24 Prot. Sciences, LLC, 2013 WL 5402089 at *9. Accordingly, the request for leave to serve a

25

26

873 (requiring the expert account for the “technological and economic differences” between

27 licenses) (emphasis added).

Case No.: 5:18-cv-02352-EJD

1 supplemental damages report is DENIED.

2 IV. CONCLUSION

3 For the foregoing reasons, the Court DENIES Plaintiff’s motion to exclude portions of

4 Dr. Almeroth’s testimony and GRANTS Defendant’s motion to exclude portions of Mr. Bratic’s

5 report. The following paragraphs shall be struck from Mr. Bratic’s report:

6  Mr. Bratic’s per-unit royalty calculations based on the BNP Agreement: Paragraphs 11,

7 135–45, 207–11, 217 of Mr. Bratic’s Expert Report (Dkt. 257-8), Paragraphs 11–12, 15 of

8 Mr. Bratic’s Supplement Report (Dkt. 257-6), and Paragraphs 70–76 of Mr. Bratic’s

9 Corrected Reply Report (Dkt. 257-7).

10 o Dr. Rubin’s opinion, which Mr. Bratic relies on, that the patented inventions

11 represent 60% of the functionality or value of PlexOS: Paragraph 382 of Dr. Rubin

12 Expert Report (Dkt. 257-10) and Paragraphs 121–24 of Dr. Rubin’s Reply Report

13 (Dkt. 257-11).

14  Mr. Bratic’s profit apportionment analysis based on Dr. Rubin’s calculations: Paragraphs

15 11, 297–203, 205–06, 212–17 of Mr. Bratic’s Expert Report (Dkt. 257-8), Paragraphs 9–

16 10, 13–15 of Mr. Bratic’s Supplement Report (Dkt. 257-6), and Paragraph 2 of Mr.

17 Bratic’s Corrected Reply Report (Dkt. 257-7).

18 o Dr. Rubin’s opinion, which Mr. Bratic relies on that 33% of the profits allegedly

19 represent the “contribution of security, reliability, and availability to the Accused

20 Operating Systems.” Paragraphs 383–86 of Dr. Rubin’s Expert Report (Dkt. 257-

21 10) and Paragraphs 133–34 of Dr. Rubin’s Reply Report (Dkt. 257-11).

22 o Dr. Rubin’s opinion, which Mr. Bratic relies upon that 33% and 50% of the value

23 of all security, reliability, and availability features on the Accused Devices are

24 attributable to EPFT and the combination of EEM and CoPP/LPTS, respectively.

25 Paragraphs 387–88 of Dr. Rubin’s Expert Report (Dkt. 257-10) and Paragraphs

26 135–36 of Dr. Rubin’s Reply Report (Dkt. 257-11).

27

Case No.: 5:18-cv-02352-EJD

1 o Dr. Rubin’s opinion, which Mr. Bratic relies upon that 70% and 40% of EPFT and

2 the combination of EEM and CoPP/LPTS, respectively, is allegedly attributable to

3 the Patents-in-Suit. Paragraphs 389-90 of Dr. Rubin’s Expert Report (Dkt. 257-10)

4 and Paragraphs 138-44 of Dr. Rubin’s Reply Report (Dkt. 257-11).

5 IT IS SO ORDERED.

6 Dated: March 10, 2020

7

EDWARD J. DAVILA

8 United States District Judge

9

10

11

12

13

©

15

16

&

Z 18

19

20

21

22

23

24

25

26

27

Case No.: 5:18-cv-02352-EJD

28 || ORDER DENYING PLAINTIFF’S MOTION TO STRIKE; GRANTING DEFENDANT'S

MOTION TO STRIKE

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.